3
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Pain
12
Breast Neoplasms
4
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma
2
Depression
2
Colonic Neoplasms
2
Vomiting
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Peripheral Nervous System Diseases
1
Pain, Postoperative
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Nausea
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Mucositis
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Interventions
Bupivacaine
32
Ropivacaine
19
Saline Solution
17
Dexmedetomidine
17
Morphine
12
Ketamine
11
Sodium Chloride
10
Acetaminophen
10
Lidocaine
9
Pregabalin
7
Control Groups
7
Dexamethasone
5
Gabapentin
4
Epinephrine
4
Anesthetics, Local
4
Analgesia, Patient-Controlled
4
parecoxib
3
oxycodone-acetaminophen
3
Tea
3
Surgical Procedures, Operative
3
Midazolam
3
Ketorolac
3
Injections, Epidural
3
Fentanyl
3
Esketamine
3
Dental Occlusion
3
Anti-Inflammatory Agents, Non-Steroidal
3
Anesthesia, General
3
Analgesics, Opioid
3
Vitamins
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pain, Postoperative
×
Analgesia
×
Clear all
NCT05876390
2026-04-16
IRACPoP
Niguarda Hospital
Enrolling by invitation
1,500 enrolled